Rezultati - Higashi, Morihiro
- Showing 1 - 20 results of 20
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma od Yamashita, Takahisa, Higashi, Morihiro, Momose, Shuji, Adachi, Akiko, Watanabe, Toshiki, Tanaka, Yuka, Tokuhira, Michihide, Kizaki, Masahiro, Tamaru, Jun-ichi
Izdano 2020Text -
10
CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma od Higashi, Morihiro, Momose, Shuji, Takayanagi, Natsuko, Tanaka, Yuka, Anan, Tomoe, Yamashita, Takahisa, Kikuchi, Jun, Tokuhira, Michihide, Kizaki, Masahiro, Tamaru, Jun‐ichi
Izdano 2022Text -
11
Postoperative lumbar spinal stenosis after intertransverse fusion with granules of hydroxyapatite: a case report od Inoue, Gen, Ohtori, Seiji, Ozawa, Tomoyuki, Ito, Toshinori, Higashi, Morihiro, Yamauchi, Kazuyo, Orita, Sumihisa, Nakamura, Junichi, Toyone, Tomoaki, Takaso, Masashi, Takahashi, Kazuhisa
Izdano 2012Text -
12
-
13
Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma od Kumagai, Youichi, Sobajima, Jun, Higashi, Morihiro, Ishiguro, Toru, Fukuchi, Minoru, Ishibashi, Keiichiro, Mochiki, Erito, Yakabi, Koji, Kawano, Tatsuyuki, Tamaru, Jun-ichi, Ishida, Hideyuki
Izdano 2015Text -
14
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas od Tanaka, Yuka, Momose, Shuji, Tabayashi, Takayuki, Sawada, Keisuke, Yamashita, Takahisa, Higashi, Morihiro, Sagawa, Morihiko, Tokuhira, Michihide, Rosenwald, Andreas, Kizaki, Masahiro, Tamaru, Jun‐ichi
Izdano 2020Text -
15
Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia od Giménez, Neus, Schulz, Ralph, Higashi, Morihiro, Aymerich, Marta, Villamor, Neus, Delgado, Julio, Juan, Manel, López-Guerra, Mònica, Campo, Elias, Rosich, Laia, Seiffert, Martina, Colomer, Dolors
Izdano 2019Text -
16
Endocytoscopic observation with methylene blue staining for duodenal neoplasms associated with familial adenomatous polyposis od Kumagai, Youichi, Yamamoto, Eisuke, Higashi, Morihiro, Ishiguro, Toru, Hatano, Satoshi, Toyomasu, Yoshitaka, Amano, Kunihiko, Suzuki, Okihide, Ishibashi, Kei-ichiro, Mochiki, Erito, Tamaru, Jun-ichi, Ishida, Hideyuki
Izdano 2020Text -
17
Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy od Yano, Hiromu, Fujiwara, Yukio, Horlad, Hasita, Pan, Chang, Kai, Keitaro, Niino, Daisuke, Ohsawa, Kumiko, Higashi, Morihiro, Nosaka, Kisato, Okuno, Yutaka, Tamaru, Jun‐ichi, Mukasa, Akitake, Matsuoka, Masao, Komohara, Yoshihiro
Izdano 2022Text -
18
The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis od Tokuhira, Michihide, Tabayashi, Takayuki, Tanaka, Yuka, Takahashi, Yasuyuki, Kimura, Yuta, Tomikawa, Tatsuki, Anan-Nemoto, Tomoe, Momose, Shuju, Higashi, Morihiro, Okuyama, Ayumi, Watanabe, Reiko, Amano, Koichi, Tamaru, Jun-ichi, Kizaki, Masahiro
Izdano 2017Text -
19
The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders od Tokuhira, Michihide, Tanaka, Yuka, Takahashi, Yasuyuki, Kimura, Yuta, Tomikawa, Tatsuki, Anan, Tomoe, Watanabe, Junichi, Sagawa, Morihiko, Higashi, Morihiro, Momose, Shuju, Amano, Koichi, Tabayashi, Takayuki, Nakaseko, Reiko, Tamaru, Jun-ichi, Kizaki, Masahiro
Izdano 2020Text -
20
Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy od Silkenstedt, Elisabeth, Arenas, Fabian, Colom-Sanmartí, Berta, Xargay-Torrent, Sílvia, Higashi, Morihiro, Giró, Ariadna, Rodriguez, Vanina, Fuentes, Patricia, Aulitzky, Walter E., van der Kuip, Heiko, Beà, Sílvia, Toribio, Maria L., Campo, Elias, López-Guerra, Mònica, Colomer, Dolors
Izdano 2019Text